Jushi Holdings (JUSHF) EBT Margin (2021 - 2026)

Jushi Holdings' (JUSHF) quarterly EBT Margin came in at 16.75% in Q1 2026, down 417.0% year-on-year from 5.29% in Q1 2025, and down 37.89% on a QoQ basis from 12.15% in Q4 2025.

Jushi Holdings (JUSHF) EBT Margin (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of EBT Margin data on file, last reported at 16.75% in Q1 2026.

  • On a quarterly basis, EBT Margin fell 417.0% year-over-year to 16.75% in Q1 2026; TTM through Mar 2026 was 13.82%, a 734.0% decrease from a year earlier, with the FY2025 full-year figure at 12.78%, down 612.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 16.75%, down from 12.15% in the prior quarter.
  • Over the last five years, EBT Margin for JUSHF reached as high as 27.18% in Q2 2022 and fell as low as 184.12% in Q4 2022.
  • Historically, EBT Margin has averaged 23.76% across 5 years, with a median of 13.15% in 2024.
  • Across the five-year window, EBT Margin plunged 20662 bps in 2022 and soared 16508 bps in 2023, its largest moves.
  • Year by year, EBT Margin stood at 184.12% in 2022, then jumped by 90 bps to 19.04% in 2023, then advanced by 29 bps to 13.48% in 2024, then gained by 10 bps to 12.15% in 2025, then plunged by 38 bps to 16.75% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 16.75% in Q1 2026, 12.15% in Q4 2025, and 22.63% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 10.97%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 33.51%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -41.57%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.73%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -7.05%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 30.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.35%
10 Jushi Holdings 81.25 Mn 41.54 Mn 29.88 Mn -16.75%

Historic Data

Download Data
DateValue
Mar 31, 2026 -16.75%
Dec 31, 2025 -12.15%
Sep 30, 2025 -22.63%
Jun 30, 2025 -3.69%
Mar 31, 2025 -12.59%
Dec 31, 2024 -13.48%
Sep 30, 2024 -11.44%
Jun 30, 2024 11.44%
Mar 31, 2024 -13.15%
Dec 31, 2023 -19.04%
Sep 30, 2023 -19.29%
Jun 30, 2023 -8.26%
Mar 31, 2023 -3.28%
Dec 31, 2022 -184.12%
Sep 30, 2022 -78.96%
Jun 30, 2022 27.18%
Mar 31, 2022 -23.76%
Dec 31, 2021 22.50%
Sep 30, 2021 85.24%
Jun 30, 2021 18.86%